Cancer Immunology and Immunotherapy
The recent FDA approval of Provenge® as the first therapeutic cancer vaccine together with the recent demonstration that Ipilimumab®, a monoclonal antibody that blocks the negative immune checkpoint cytotoxic T lymphocyte associated antigen-4, prolongs patient survival are major achievements that us...
Salvato in:
| Ente Autore: | |
|---|---|
| Altri autori: | |
| Natura: | Elettronico eBook |
| Lingua: | English |
| Pubblicazione: |
Berlin, Heidelberg :
Springer Berlin Heidelberg : Imprint: Springer,
2011.
|
| Edizione: | 1st ed. 2011. |
| Serie: | Current Topics in Microbiology and Immunology,
344 |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1007/978-3-642-14136-2 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|
Lascia un commento!